Submit Your Feeds

Business News • PR NewsWire • Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS

Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS

THOUSAND OAKS, Calif., Dec. 10, 2010 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) today announced results from new analyses comparing XGEVA™ (denosumab), the first new treatment for advanced cancer patients with bone metastases in nearly a decade to prevent skeletal-related events, to Zometa

View More : http://www.prnewswire.com/news-releases/amgen-presents-new-xgeva-denosumab-breast-cancer-skeletal-related-event-preventi...
Releted News by prnewswire
Shrink Nanotechnologies Acquires Exclusive Worldwide License to 'Electronic Glue'; Nanocrystal Technology Holds the Potential to Bring Low Cost Printed Roll-to-Roll Processes to the Solar Industry and Other Printed Semiconductor Applications
Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS
Dodge Brand Teams Up With Hart and Huntington Racing, Famed Freestyle Motocross Star and Team Owner Carey Hart
Home Sitemap Contact Us
© businessNewsNewsNews.com